These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34369236)

  • 1. Dual inhibition of EGFR and IL-6-STAT3 signalling by miR-146b: a potential targeted therapy for epithelial ovarian cancer.
    Yan M; Han M; Yang X; Shen R; Wang H; Zhang L; Xia S; Yang P; Zhai G; Shao Q
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1905-1915. PubMed ID: 34369236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway.
    Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.
    Yue P; Zhang X; Paladino D; Sengupta B; Ahmad S; Holloway RW; Ingersoll SB; Turkson J
    Oncogene; 2012 May; 31(18):2309-22. PubMed ID: 21909139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.
    Wen W; Wu J; Liu L; Tian Y; Buettner R; Hsieh MY; Horne D; Dellinger TH; Han ES; Jove R; Yim JH
    Mol Cancer; 2015 May; 14():100. PubMed ID: 25928246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-κB to IL-6 signaling axis and STAT3-driven cancer phenotypes.
    Xiang M; Birkbak NJ; Vafaizadeh V; Walker SR; Yeh JE; Liu S; Kroll Y; Boldin M; Taganov K; Groner B; Richardson AL; Frank DA
    Sci Signal; 2014 Jan; 7(310):ra11. PubMed ID: 24473196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.
    Colomiere M; Ward AC; Riley C; Trenerry MK; Cameron-Smith D; Findlay J; Ackland L; Ahmed N
    Br J Cancer; 2009 Jan; 100(1):134-44. PubMed ID: 19088723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal regulation of miR-206 and IL-6/STAT3 pathway mediates IL6-induced gefitinib resistance in EGFR-mutant lung cancer cells.
    Yang Y; Wang W; Chang H; Han Z; Yu X; Zhang T
    J Cell Mol Med; 2019 Nov; 23(11):7331-7341. PubMed ID: 31507089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA EGFR-AS1 in colorectal cancer: potential role in tumorigenesis and survival via miRNA-133b sponge and EGFR/STAT3 axis regulation.
    Atef MM; Amer AI; Hafez YM; Elsebaey MA; Saber SA; Abd El-Khalik SR
    Br J Biomed Sci; 2021 Jul; 78(3):122-129. PubMed ID: 33211633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer.
    Alberti C; Pinciroli P; Valeri B; Ferri R; Ditto A; Umezawa K; Sensi M; Canevari S; Tomassetti A
    Oncogene; 2012 Sep; 31(37):4139-49. PubMed ID: 22158046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the signal transducer and activator of transcription 3 pathway up-regulates estrogen receptor-beta expression in lung adenocarcinoma cells.
    Wang HC; Yeh HH; Huang WL; Lin CC; Su WP; Chen HH; Lai WW; Su WC
    Mol Endocrinol; 2011 Jul; 25(7):1145-58. PubMed ID: 21546410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3.
    Liu HP; Zhang Y; Liu ZT; Qi H; Zheng XM; Qi LH; Wang JY
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9286-9294. PubMed ID: 31773696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
    Kim S; Gwak H; Kim HS; Kim B; Dhanasekaran DN; Song YS
    Oncotarget; 2016 Dec; 7(50):83148-83159. PubMed ID: 27825119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of siltuximab on the interleukin-6/Stat3 signaling pathway in ovarian cancer].
    Guo YQ; Lu P; Duan ZF; Zhang Z
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):854-9. PubMed ID: 21211286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer.
    Yan M; Yang X; Shen R; Wu C; Wang H; Ye Q; Yang P; Zhang L; Chen M; Wan B; Zhang Q; Xia S; Lu X; Shao G; Zhou X; Yu J; Shao Q
    Cell Death Dis; 2018 Nov; 9(11):1123. PubMed ID: 30409964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: Targeting survival pathways to increase PDT efficacy in ovarian and lung cancer.
    Edmonds C; Hagan S; Gallagher-Colombo SM; Busch TM; Cengel KA
    Cancer Biol Ther; 2012 Dec; 13(14):1463-70. PubMed ID: 22986230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of ovarian cancer by low-intensity ultrasound through depletion of IL-6/STAT3 inflammatory pathway-maintained cancer stemness.
    Gong T; Zhang P; Jia L; Pan Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):820-826. PubMed ID: 32273089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-217 Inhibits M2-Like Macrophage Polarization by Suppressing Secretion of Interleukin-6 in Ovarian Cancer.
    Jiang B; Zhu SJ; Xiao SS; Xue M
    Inflammation; 2019 Oct; 42(5):1517-1529. PubMed ID: 31049770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
    Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J
    Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.